)
Puma Biotechnology (PBYI) investor relations material
Puma Biotechnology Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual Meeting of Stockholders scheduled for June 11, 2026, at the company's Los Angeles office.
Holders of record as of April 13, 2026, are entitled to vote on key proposals.
Proxy materials, including the annual report and proxy statement, are available online, with options for paper or email delivery.
Internet-based delivery of proxy materials aims to reduce costs and environmental impact.
Voting matters and shareholder proposals
Election of eight director nominees for a one-year term.
Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Advisory (non-binding) vote to approve executive compensation.
Approval of an amendment to extend the expiration date of a warrant held by Alan H. Auerbach until October 4, 2028.
Board recommends voting "FOR" all proposals.
Board of directors and corporate governance
Eight nominees listed for election to the board, including Alan H. Auerbach, Alessandra Cesano, Allison Dorval, Michael P. Miller, Jay M. Moyes, Adrian M. Senderowicz, Brian Stuglik, and Troy E. Wilson.
- Shareholders will vote on director elections, auditor ratification, executive pay, and a CEO warrant extension.PBYI
Proxy filing28 Apr 2026 - Annual meeting to vote on directors, auditor, executive pay, and CEO warrant extension.PBYI
Proxy filing7 Apr 2026 - Q4 2025 delivered higher NERLYNX sales, robust royalty growth, and sustained profitability.PBYI
Q4 20254 Apr 2026 - NERLYNX sales rise, alisertib progresses in trials, and profitability is maintained.PBYI
TD Cowen 46th Annual Health Care Conference2 Mar 2026 - Q2 2024 revenue rose sequentially, net loss narrowed, and FY net income is projected at $12M–$15M.PBYI
Q2 20242 Feb 2026 - Q3 2024 net income surged to $20.3M on $80.5M revenue, with strong China sales and global growth.PBYI
Q3 202415 Jan 2026 - Q4 2024 saw stable NERLYNX sales, higher net income, and a steady 2025 outlook.PBYI
Q4 202426 Dec 2025 - NERLYNX and alisertib advance with stable revenue and key clinical data expected in 2025.PBYI
TD Cowen 45th Annual Healthcare Conference17 Dec 2025 - Board recommends voting for all directors, auditor ratification, and executive pay approval.PBYI
Proxy Filing2 Dec 2025
Next Puma Biotechnology earnings date
Next Puma Biotechnology earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage